Schedule 13G ownership disclosure

Celldex Therapeutics, Inc.

Security class unavailable · CUSIP: 15117B103

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,303,079
Percent of class
10.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000728889-15-000191
Form type
SC 13G/A
Filer
CELLDEX THERAPEUTICS INC
CIK
CIK 1286517
Filed
Feb 04, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub